Report cover image

U.S. Egg Market

Publisher Grand View Research
Published Jan 22, 2026
Length 80 Pages
SKU # GV20873474

Description

U.S. Egg Market Summary

The U.S. egg market size was estimated at USD 51.70 billion in 2025 and is projected to reach USD 84.60 billion by 2033, growing at a CAGR of 6.4% from 2026 to 2033. The demand for eggs and egg products in the U.S. is increasing as consumers prefer affordable, nutrient-dense protein sources that align with modern, busy lifestyles.

Eggs and egg products offer high protein, convenience, and versatility, driving demand in protein-rich and clean-label foods.

The U.S. eggs industry continues to grow, supported by strong production capacity and steady productivity gains. According to the USDA National Agricultural Statistics Service (NASS), total egg production in the U.S. reached 109 billion eggs in 2024. The table-egg layer flock averaged around 311 million hens, maintaining high productivity levels at nearly 79 eggs per 100 layers per day. The value of egg production increased to USD 21.0 billion in 2024, up from USD 17.9 billion in 2023, reflecting volume stability and favorable pricing. These consistent productivity levels, coupled with advancements in layer management and automation, continue to strengthen supply resilience and ensure stable availability of shell, liquid, and dried egg products across food processing and retail segments nationwide.

Moreover, technological advancements and modernization across egg processing facilities are driving industry efficiency and product diversification. Investments in automation, cold chain logistics, and advanced grading systems have enhanced product quality and traceability, supporting compliance with USDA and FDA food safety standards. In addition, the shift toward cage-free and animal welfare certified production, encouraged by both consumer preferences and evolving state regulations, is reshaping supply chains and attracting premium pricing opportunities. These advancements strengthen the capacity of the market, supporting sustained growth and expanding market reach.

.S. Egg Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. egg market report based on product, production category, and end use application:
  • Product Outlook (Revenue, USD Billion, 2021 - 2033)
  • Brown Eggs
  • White Eggs
  • Production Category Outlook (Revenue, USD Billion, 2021 - 2033)
  • Cage-Free
  • Organic
  • Pasture-Raised
  • End Use Application Outlook (Revenue, USD Billion, 2021 - 2033)
  • B2B
  • Processing Industry
  • Bakery & Confectionery
  • Processed and Convenience Foods
  • Dairy and Dairy Products
  • Nutritional & Functional Food
  • Foodservice Industry
  • B2C
  • Hypermarket/Supermarket
  • Grocery Stores
  • Online
  • Company-Owned Websites
  • E-Commerce
  • Others (Wholesalers, etc.)
Please note The report will be delivered in 4-8 business days upon order notification.

Table of Contents

80 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Modality
1.1.3. Application
1.1.4. Route Of Administration
1.1.5. End use
1.1.6. Regional scope
1.1.7. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Contrast Media Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing demand for medical imaging
3.2.1.2. Approvals and launches of contrast media agents
3.2.1.3. Increasing disease burden
3.2.1.4. Technological advancements
3.2.1.5. Rising production capacities for contrast media
3.2.2. Market restraint analysis
3.2.2.1. Recalls of contrast media
3.2.2.2. Shortage of Iohexol and Iodixanol
3.2.3. Market opportunity analysis
3.2.3.1. Development of interconnected solutions in contrast agents
3.2.3.2. Growing number of clinical trials
3.2.3.3. Improvements in public and private healthcare infrastructure
3.2.3.4. Growth potential in emerging economies in contrast media market
3.2.4. Market challenge analysis
3.2.4.1. Potential complications and risks associated with contrast media
3.3. Contrast Media Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
Chapter 4. Contrast Media Market: Modality Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Contrast Media Market Modality Type Movement Analysis
4.3. Global Contrast Media Market Size & Trend Analysis, by Modality Type, 2021 to 2033 (USD Million)
4.4. Ultrasound
4.4.1. Ultrasound market estimates and forecasts for 2021 to 2033 (USD Million)
4.5. Magnetic Resonance Imaging
4.5.1. Magnetic resonance imaging market estimates and forecasts for 2021 to 2033 (USD Million)
4.6. X-ray/Computed Tomography
4.6.1. X-ray/computed tomography market estimates and forecasts for 2021 to 2033 (USD Million)
Chapter 5. Contrast Media Market: Product Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Contrast Media Market Product Movement Analysis
5.3. Global Contrast Media Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
5.4. Microbubble
5.4.1. Microbubble market estimates and forecasts for 2021 to 2033 (USD Million)
5.5. Gadolinium-Based
5.5.1. Gadolinium-based market estimates and forecasts for 2021 to 2033 (USD Million)
5.6. Iodinated
5.6.1. Iodinated market estimates and forecasts for 2021 to 2033 (USD Million)
5.7. Barium-based
5.7.1. Barium-based market estimates and forecasts for 2021 to 2033 (USD Million)
Chapter 6. Contrast Media Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Contrast Media Market Application Movement Analysis
6.3. Global Contrast Media Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Cardiovascular Disorders
6.4.1. Cardiovascular disorders market estimates and forecast 2021 to 2033 (USD Million)
6.5. Neurological Disorders
6.5.1. Neurological disorders market estimates and forecast 2021 to 2033 (USD Million)
6.6. Gastrointestinal Disorders
6.6.1. Gastrointestinal disorders market estimates and forecast 2021 to 2033 (USD Million)
6.7. Cancer
6.7.1. Cancer market estimates and forecast 2021 to 2033 (USD Million)
6.8. Nephrological Disorders
6.8.1. Nephrological disorders market estimates and forecast 2021 to 2033 (USD Million)
6.9. Musculoskeletal Disorders
6.9.1. Musculoskeletal disorders market estimates and forecast 2021 to 2033 (USD Million)
6.10. Others
6.10.1. Others market estimates and forecast 2021 to 2033 (USD Million)
Chapter 7. Contrast Media Market: Route of Administration Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Contrast Media Market Route Of Administration Movement Analysis
7.3. Global Contrast Media Market Size & Trend Analysis, by Route Of Administration, 2021 to 2033 (USD Million)
7.4. Intravenous
7.4.1. Intravenous market estimates and forecast 2021 to 2033 (USD Million)
7.5. Oral Route
7.5.1. Oral route market estimates and forecast 2021 to 2033 (USD Million)
7.6. Rectal Route
7.6.1. Rectal route market estimates and forecast 2021 to 2033 (USD Million)
Chapter 8. Contrast Media Devices: End Use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Global Contrast Media Market End Use Movement Analysis
8.3. Global Contrast Media Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
8.4. Hospitals
8.4.1. Hospitals market estimates and forecasts for 2021 to 2033 (USD Million)
8.5. Diagnostic Imaging Centers
8.5.1. Diagnostic imaging centers market estimates and forecasts for 2021 to 2033 (USD Million)
8.6. Others
8.6.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
Chapter 9. Contrast Media Market: Regional Estimates & Trend Analysis By Product, By Modality, By Application, By Route of Administration, By End Use
9.1. Regional Dashboard
9.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
9.3. North America
9.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
9.3.2. U.S.
9.3.2.1. Key country dynamics
9.3.2.2. Competitive scenario
9.3.2.3. Regulatory framework
9.3.2.4. Reimbursement scenario
9.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
9.3.3. Canada
9.3.3.1. Key country dynamics
9.3.3.2. Competitive scenario
9.3.3.3. Regulatory framework
9.3.3.4. Reimbursement scenario
9.3.3.5. Canada market estimates and forecasts, 2021 - 2033
9.3.4. Mexico
9.3.4.1. Key country dynamics
9.3.4.2. Competitive scenario
9.3.4.3. Regulatory framework
9.3.4.4. Reimbursement scenario
9.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
9.4. Europe
9.4.1. UK
9.4.1.1. Key country dynamics
9.4.1.2. Competitive scenario
9.4.1.3. Regulatory framework
9.4.1.4. Reimbursement scenario
9.4.1.5. UK market estimates and forecasts, 2021 - 2033
9.4.2. Germany
9.4.2.1. Key country dynamics
9.4.2.2. Competitive scenario
9.4.2.3. Regulatory framework
9.4.2.4. Reimbursement scenario
9.4.2.5. Germany market estimates and forecasts, 2021 - 2033
9.4.3. France
9.4.3.1. Key country dynamics
9.4.3.2. Competitive scenario
9.4.3.3. Regulatory framework
9.4.3.4. Reimbursement scenario
9.4.3.5. France market estimates and forecasts, 2021 - 2033
9.4.4. Italy
9.4.4.1. Key country dynamics
9.4.4.2. Competitive scenario
9.4.4.3. Regulatory framework
9.4.4.4. Reimbursement scenario
9.4.4.5. Italy market estimates and forecasts, 2021 - 2033
9.4.5. Spain
9.4.5.1. Key country dynamics
9.4.5.2. Competitive scenario
9.4.5.3. Regulatory framework
9.4.5.4. Reimbursement scenario
9.4.5.5. Spain market estimates and forecasts, 2021 - 2033
9.4.6. Denmark
9.4.6.1. Key country dynamics
9.4.6.2. Competitive scenario
9.4.6.3. Regulatory framework
9.4.6.4. Reimbursement scenario
9.4.6.5. Denmark market estimates and forecasts, 2021 - 2033
9.4.7. Sweden
9.4.7.1. Key country dynamics
9.4.7.2. Competitive scenario
9.4.7.3. Regulatory framework
9.4.7.4. Reimbursement scenario
9.4.7.5. Sweden market estimates and forecasts, 2021 - 2033
9.4.8. Norway
9.4.8.1. Key country dynamics
9.4.8.2. Competitive scenario
9.4.8.3. Regulatory framework
9.4.8.4. Reimbursement scenario
9.4.8.5. Norway market estimates and forecasts, 2021 - 2033
9.5. Asia Pacific
9.5.1. Japan
9.5.1.1. Key country dynamics
9.5.1.2. Competitive scenario
9.5.1.3. Regulatory framework
9.5.1.4. Reimbursement scenario
9.5.1.5. Japan market estimates and forecasts, 2021 - 2033
9.5.2. India
9.5.2.1. Key country dynamics
9.5.2.2. Competitive scenario
9.5.2.3. Regulatory framework
9.5.2.4. Reimbursement scenario
9.5.2.5. India market estimates and forecasts, 2021 - 2033
9.5.3. China
9.5.3.1. Key country dynamics
9.5.3.2. Competitive scenario
9.5.3.3. Regulatory framework
9.5.3.4. Reimbursement scenario
9.5.3.5. China market estimates and forecasts, 2021 - 2033
9.5.4. South Korea
9.5.4.1. Key country dynamics
9.5.4.2. Competitive scenario
9.5.4.3. Regulatory framework
9.5.4.4. Reimbursement scenario
9.5.4.5. South Korea market estimates and forecasts, 2021 - 2033
9.5.5. Australia
9.5.5.1. Key country dynamics
9.5.5.2. Competitive scenario
9.5.5.3. Regulatory framework
9.5.5.4. Reimbursement scenario
9.5.5.5. Australia market estimates and forecasts, 2021 - 2033
9.5.6. Thailand
9.5.6.1. Key country dynamics
9.5.6.2. Competitive scenario
9.5.6.3. Regulatory framework
9.5.6.4. Reimbursement scenario
9.5.6.5. Thailand market estimates and forecasts, 2021 - 2033
9.6. Latin America
9.6.1. Brazil
9.6.1.1. Key country dynamics
9.6.1.2. Competitive scenario
9.6.1.3. Regulatory framework
9.6.1.4. Reimbursement scenario
9.6.1.5. Brazil market estimates and forecasts, 2021 - 2033
9.6.2. Argentina
9.6.2.1. Key country dynamics
9.6.2.2. Competitive scenario
9.6.2.3. Regulatory framework
9.6.2.4. Reimbursement scenario
9.6.2.5. Argentina market estimates and forecasts, 2021 - 2033
9.7. MEA
9.7.1. South Africa
9.7.1.1. Key country dynamics
9.7.1.2. Competitive scenario
9.7.1.3. Regulatory framework
9.7.1.4. Reimbursement scenario
9.7.1.5. South Africa market estimates and forecasts, 2021 - 2033
9.7.2. Saudi Arabia
9.7.2.1. Key country dynamics
9.7.2.2. Competitive scenario
9.7.2.3. Regulatory framework
9.7.2.4. Reimbursement scenario
9.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
9.7.3. UAE
9.7.3.1. Key country dynamics
9.7.3.2. Competitive scenario
9.7.3.3. Regulatory framework
9.7.3.4. Reimbursement scenario
9.7.3.5. UAE market estimates and forecasts, 2021 - 2033
9.7.4. Kuwait
9.7.4.1. Key country dynamics
9.7.4.2. Competitive scenario
9.7.4.3. Regulatory framework
9.7.4.4. Reimbursement scenario
9.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Company/Competition Categorization
10.2.1. Innovators
10.3. Vendor Landscape
10.3.1. List of key distributors and channel partners
10.3.2. Key customers
10.3.3. Global Key company market share analysis, 2024
10.3.4. Bayer AG
10.3.4.1. Company overview
10.3.4.2. Financial performance
10.3.4.3. Product benchmarking
10.3.4.4. Strategic initiatives
10.3.5. GE Healthcare
10.3.5.1. Company overview
10.3.5.2. Financial performance
10.3.5.3. Product benchmarking
10.3.5.4. Strategic initiatives
10.3.6. Beijing Beilu Pharmaceutical Co., Ltd.
10.3.6.1. Company overview
10.3.6.2. Financial performance
10.3.6.3. Product benchmarking
10.3.6.4. Strategic initiatives
10.3.7. Guerbet
10.3.7.1. Company overview
10.3.7.2. Financial performance
10.3.7.3. Product benchmarking
10.3.7.4. Strategic initiatives
10.3.8. Arco Lifesciences (I) Pvt. Ltd.
10.3.8.1. Company overview
10.3.8.2. Financial performance
10.3.8.3. Product benchmarking
10.3.8.4. Strategic initiatives
10.3.9. Livealth
10.3.9.1. Company overview
10.3.9.2. Financial performance
10.3.9.3. Product benchmarking
10.3.9.4. Strategic initiatives
10.3.10. JB Pharma
10.3.10.1. Company overview
10.3.10.2. Financial performance
10.3.10.3. Product benchmarking
10.3.10.4. Strategic initiatives
10.3.11. Blue Jet Healthcare.
10.3.11.1. Company overview
10.3.11.2. Financial performance
10.3.11.3. Product benchmarking
10.3.11.4. Strategic initiatives
10.3.12. Bracco Diagnostic, Inc.
10.3.12.1. Company overview
10.3.12.2. Financial performance
10.3.12.3. Product benchmarking
10.3.12.4. Strategic initiatives
10.3.13. Fresenius Kabi USA, LLC
10.3.13.1. Company overview
10.3.13.2. Financial performance
10.3.13.3. Product benchmarking
10.3.13.4. Strategic initiatives
10.3.14. Voyageur Pharmaceuticals, Ltd
10.3.14.1. Company overview
10.3.14.2. Financial performance
10.3.14.3. Product benchmarking
10.3.14.4. Strategic initiatives
10.3.15. Grupo Juste
10.3.15.1. Company overview
10.3.15.2. Financial performance
10.3.15.3. Product benchmarking
10.3.15.4. Strategic initiatives
10.3.16. Lantheus Holdings, Inc.
10.3.16.1. Company overview
10.3.16.2. Financial performance
10.3.16.3. Product benchmarking
10.3.16.4. Strategic initiatives
10.3.17. iMAX
10.3.17.1. Company overview
10.3.17.2. Financial performance
10.3.17.3. Product benchmarking
10.3.17.4. Strategic initiatives
10.3.18. Trivitron Healthcare
10.3.18.1. Company overview
10.3.18.2. Financial performance
10.3.18.3. Product benchmarking
10.3.18.4. Strategic initiatives
10.3.19. Jodas Expoim Pvt. Ltd.
10.3.19.1. Company overview
10.3.19.2. Financial performance
10.3.19.3. Product benchmarking
10.3.19.4. Strategic initiatives
10.4. Heat Map Analysis/ Company Market Position Analysis
10.5. Estimated Company Market Share Analysis, 2025
10.6. List of Other Key Market Players

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us